1h Free Analyst Time
The Antimicrobial Resistance Surveillance Market size was estimated at USD 5.60 billion in 2023, USD 5.96 billion in 2024, and is expected to grow at a CAGR of 6.49% to reach USD 8.71 billion by 2030.The antimicrobial resistance surveillance market encompasses products to monitor, analyze, and control the spread of microorganisms that develop resistance to antibiotics, antivirals, antifungals, and other antimicrobial agents. The primary application of antimicrobial resistance surveillance is to provide information on the prevalence of resistant pathogens in various settings such as hospitals, community health centers, food production facilities, animal husbandry operations, water treatment plants, and environmental samples. The increasing prevalence of multidrug-resistant organisms worldwide necessitates constant monitoring to adapt existing treatments appropriately. Advances in molecular diagnostics techniques enable early detection and identification of antibiotic-resistant strains. Addtionally, growing awareness about antibiotic stewardship programs among healthcare professionals encourages prudent prescribing practices. Despite the growth prospects, several challenges hinder the antimicrobial resistance surveillance market progress. Inadequate infrastructure and funding in low and middle-income countries result in limited surveillance capabilities. Variability in laboratory methodologies employed worldwide hampers comparability of results across regions. However, the emergence of point-of-care testing devices expedites diagnosis and enables personalized treatment decisions. Harnessing genomic sequencing technologies allows for accurate tracking of resistance mechanisms and transmission dynamics at a population level. Along with these, to sustain business growth and contribute to global health security, stakeholders should focus on key areas like refining diagnostic tools for faster detection, exploring unconventional treatment approaches, utilizing artificial intelligence for predictive modeling. Speak directly to the analyst to clarify any post sales queries you may have.
Regional Insights
Antimicrobial resistance (AMR) has emerged as a significant public health threat across the Americas and Europe. Continuous surveillance of AMR is crucial in understanding the growing impact on healthcare systems, guiding policy decisions, and implementing effective strategies to mitigate the risks associated with resistant infections. The major driving factors behind increased AMR levels in the Americas and Europe include the overuse and misuse of antimicrobials in human medicine, veterinary practice, agriculture, and food production sectors. In developed countries across the Americas and Europe, stringent regulatory frameworks govern the actions of manufacturers and providers of antimicrobial products. The potential associated with emerging countries in addressing AMR is immense due to factors such as rapid economic growth, increasing healthcare expenditure, and favorable government policies. Emerging economies like India, China, and Brazil are investing heavily in R&D for antimicrobial resistance surveillance and promoting public-private partnerships to address the issue. Governments provide financial support for research and development (R&D) efforts to incentivize innovation in addressing antimicrobial resistance. For instance, in August 2023, the UK government made a significant investment of £210 million to enhance global surveillance of drug-resistant bacteria, a critical aspect of Antimicrobial Resistance (AMR) surveillance. However, initiatives focusing on surveillance systems enhancement, regulatory oversight improvements, investment in research, and development of new treatments are crucial to combating this threat effectively.FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Antimicrobial Resistance Surveillance Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antimicrobial Resistance Surveillance Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.Key Company Profiles
The report delves into recent significant developments in the Antimicrobial Resistance Surveillance Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accelerate Diagnostics, Inc., Becton, Dickinson and Company, bioMérieux SA, Cepheid, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Johnson & Johnson Services Inc., Liofilchem S.r.l., Lumed, Luminex Corporation, Merck & Co., Inc., Novo Holdings A/S, OpGen, Inc., Pfizer Inc., QIAGEN GmbH, Sanofi S.A., Thermo Fisher Scientific Inc., Venatorx Pharmaceuticals, Inc., Viatris Inc., Vivli Inc., and Wolters Kluwer N.V.Market Segmentation & Coverage
This research report categorizes the Antimicrobial Resistance Surveillance Market to forecast the revenues and analyze trends in each of the following sub-markets:- Component
- Diagnostic Kits
- Diagnostic Systems
- Services
- Software
- End-User
- Hospitals
- Research & Academic Institutes
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the Antimicrobial Resistance Surveillance Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antimicrobial Resistance Surveillance Market?
- What are the technology trends and regulatory frameworks in the Antimicrobial Resistance Surveillance Market?
- What is the market share of the leading vendors in the Antimicrobial Resistance Surveillance Market?
- Which modes and strategic moves are suitable for entering the Antimicrobial Resistance Surveillance Market?
Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.
This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. Antimicrobial Resistance Surveillance Market, by Component
7. Antimicrobial Resistance Surveillance Market, by End-User
8. Americas Antimicrobial Resistance Surveillance Market
9. Asia-Pacific Antimicrobial Resistance Surveillance Market
10. Europe, Middle East & Africa Antimicrobial Resistance Surveillance Market
11. Competitive Landscape
12. Competitive Portfolio
13. Appendix
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories
- Accelerate Diagnostics, Inc.
- Becton, Dickinson and Company
- bioMérieux SA
- Cepheid
- F. Hoffmann-La Roche Ltd
- GlaxoSmithKline PLC
- Johnson & Johnson Services Inc.
- Liofilchem S.r.l.
- Lumed
- Luminex Corporation
- Merck & Co., Inc.
- Novo Holdings A/S
- OpGen, Inc.
- Pfizer Inc.
- QIAGEN GmbH
- Sanofi S.A.
- Thermo Fisher Scientific Inc.
- Venatorx Pharmaceuticals, Inc.
- Viatris Inc.
- Vivli Inc.
- Wolters Kluwer N.V.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 195 |
| Published | March 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 5.96 Billion |
| Forecasted Market Value ( USD | $ 8.71 Billion |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
